SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-207846
Filing Date
2022-08-01
Accepted
2022-08-01 09:00:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d385673d424b5.htm 424B5 311851
2 GRAPHIC g385673g16e35.jpg GRAPHIC 51559
  Complete submission text file 0001193125-22-207846.txt   377408
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-257821 | Film No.: 221122962
SIC: 2836 Biological Products, (No Diagnostic Substances)